A detailed history of Catalyst Capital Advisors LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Catalyst Capital Advisors LLC holds 2,150 shares of MEDP stock, worth $717,003. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,150
Holding current value
$717,003
% of portfolio
0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$372.0 - $424.34 $799,800 - $912,331
2,150 New
2,150 $885,000
Q4 2019

Feb 06, 2020

SELL
$70.08 - $84.64 $5,606 - $6,771
-80 Closed
0 $0
Q3 2019

Nov 05, 2019

BUY
$62.38 - $85.89 $4,990 - $6,871
80 New
80 $7,000
Q1 2019

May 08, 2019

SELL
$49.38 - $70.58 $2,222 - $3,176
-45 Closed
0 $0
Q4 2018

Feb 07, 2019

SELL
$46.97 - $63.98 $704 - $959
-15 Reduced 25.0%
45 $2,000
Q3 2018

Nov 08, 2018

BUY
$43.25 - $63.74 $2,595 - $3,824
60 New
60 $4,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Catalyst Capital Advisors LLC Portfolio

Follow Catalyst Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Capital Advisors LLC with notifications on news.